My‐Hanh Lam
Pfizer (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Biosimilars and Bioanalytical Methods, HER2/EGFR in Cancer Research, Crystallization and Solubility Studies
Most-Cited Works
- → Niemann-Pick C1 Like 1 (NPC1L1) Is the Intestinal Phytosterol and Cholesterol Transporter and a Key Modulator of Whole-body Cholesterol Homeostasis(2004)691 cited
- → Tumor Cells Chronically Treated with a Trastuzumab–Maytansinoid Antibody–Drug Conjugate Develop Varied Resistance Mechanisms but Respond to Alternate Treatments(2015)259 cited
- → Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects.(1985)155 cited
- → Discovery of Cytotoxic Dolastatin 10 Analogues with N-Terminal Modifications(2014)131 cited
- → Ionic and GTP regulation of binding of platelet-activating factor to receptors and platelet-activating factor-induced activation of GTPase in rabbit platelet membranes.(1986)123 cited
- → trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor.(1985)121 cited
- → A Potent Synthetic LXR Agonist Is More Effective than Cholesterol Loading at Inducing ABCA1 mRNA and Stimulating Cholesterol Efflux(2002)121 cited
- → Specific binding sites for platelet activating factor in human lung tissues(1985)115 cited
- → Synthesis, Molecular Editing, and Biological Assessment of the Potent Cytotoxin Leiodermatolide(2014)93 cited
- → Total Syntheses and Biological Reassessment of Lactimidomycin, Isomigrastatin and Congener Glutarimide Antibiotics(2013)91 cited